SLC12A2: A Protein Associated with Diverse Cellular Processes and Diseases

Target Name: SLC12A2-DT

NCBI ID: G644873

SLC12A2-DT

Other Name(s): SLC12A2 divergent transcript | SLC12A2 divergent transcript, transcript variant 1 | LINC01184 | SLC12A2-DT variant 1

SLC12A2: A Protein Associated with Diverse Cellular Processes and Diseases

SLC12A2-DT, or small nuclear polyprotein gene (SNP), is a gene that encodes a protein known as SLC12A2. The SLC12A2 protein is a member of the SLC gene family, which is responsible for transporting a variety of substances across cell membranes. The SLC12A2 protein is a divergent transcript, which means that it has been shaped by evolutionary pressures and is different from the ancestral form of the gene.

SLC12A2 is a protein that is expressed in many different tissues and organs, including the brain, heart, and kidneys. It is also involved in a number of different cellular processes, including cell signaling, protein transport, and chromatin structure.

One of the key features of the SLC12A2 protein is its ability to interact with other proteins. This is accomplished through the use of its transmembrane domain, which is a region of the protein that spans the cell membrane and allows it to interact with other proteins on the other side.

SLC12A2 has also been shown to play a role in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In particular, it is often used as a biomarker for diseases that are characterized by the accumulation of protein aggregates in the brain, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, SLC12A2 is also of interest as a potential biomarker for a number of diseases. Its ability to interact with other proteins and its involvement in the development of protein aggregates in the brain make it a promising candidate for a variety of neurodegenerative diseases.

Overall, SLC12A2-DT is a protein that is worth further research as a potential drug target and biomarker. Its unique structure and function, as well as its involvement in a number of diseases, make it a valuable tool for scientists and clinicians alike.

Protein Name: SLC12A2 Divergent Transcript

The "SLC12A2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC12A2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets